Select Medical (NYSE:SEM) leaves NYSE after $3.9B buyout, one-cent deal spread
2 July 2026

Select Medical (NYSE:SEM) leaves NYSE after $3.9B buyout, one-cent deal spread

NEW YORK, July 2, 2026, 10:07 EDT

  • Select Medical Holdings Corporation last traded at $16.51, just a penny above the $16.50 per share cash buyout, before NYSE halted and started delisting its shares.
  • The merger took effect at 12:01 a.m. July 1. The company asked the NYSE to halt trading before the market opened that day.
  • SEM was dropped from the S&P SmallCap 600 and Gulfport Energy Corp took its place ahead of the July 1 open, according to S&P Dow Jones Indices.
  • U.S. equities traded Thursday. NYSE will close Friday, July 3, for Independence Day observed, according to the New York Stock Exchange.

Select Medical Holdings Corporation closed its run on the New York Stock Exchange with shares finishing nearly right at the cash price for its merger. That wrapped up its time in the market as an option on hospitals, rehab clinics, and steady cash flow.

Select Medical, based in Mechanicsburg, Pennsylvania, said June 30 it wrapped up its sale to a group led by Executive Chairman and co-founder Robert A. Ortenzio, Senior EVP of Strategic Finance and Operations Martin F. Jackson, and Welsh, Carson, Anderson & Stowe. Shareholders get $16.50 per share in cash, putting Select Medical’s value near $3.9 billion, according to the company. The merger closed at 12:01 a.m. on July 1. SEM stopped trading and lost its NYSE listing the same day.

SEM last traded at $16.51, off a penny from the previous close. Volume hit 27.8 million shares. That’s a 0.06% premium to cash at $16.50. The stock’s high before the halt was $16.56, six cents above the cash price.

SEM deal/market lineFigure
SEM last traded at$16.51
Merger cash price$16.50
Premium to merger cash+$0.01, or +0.06%
High and low before halt$16.56 / $16.51
Latest volume shown27.8 million shares
Market value at last price$2.05 billion
Total paid for common shares, excluding rollover and carve-outsabout $1.7 billion
Shares assumed cashed at $16.50about 103.0 million
Total shares by market cap mathabout 124.0 million

The spread is key here since public holders are done with the trade, but the business isn’t. According to the SEC filing, every common share on record before the deal closed, except for rollover, restricted, excluded and appraisal shares, gets $16.50 cash. The filing also notes rollover shares went to the parent and were canceled with no payment.

Filings and quote data suggest around 21 million implied shares aren’t included in the $1.7 billion cash-paid figure. That’s about 17% of the total implied shares in the final market cap. According to the filing, the money comes from equity from WCAS, some holder rollovers and outside debt.

The proxy gives the reason behind the final one-cent spread. Daniel J. Thomas, who chairs the special committee, told Ortenzio $16.00 per share was “inadequate,” the proxy says. Ortenzio later replied that anything above $16.50 “would not be possible.” The special committee raised its number to $16.50 and told Ortenzio it would not accept anything lower. SEC

Goldman Sachs & Co. LLC, which advised the special committee, called the $16.50 cash offer “fair from a financial point of view” for holders other than the excluded holders, according to its opinion. Goldman said its opinion relied on certain assumptions and limits, and it wasn’t required to update the opinion for later events. SEC

The index move hit right away. S&P Dow Jones Indices dropped Select Medical from the S&P SmallCap 600 and brought in Gulfport Energy Corp before the open July 1, shifting a slot from health care to energy. Gulfport was up 2.25% at $169.13 early Thursday.

Stock or ETFLatest priceChange
Select Medical Holdings Corporation $16.51-0.06%
Encompass Health Corp (NYSE:EHC)$104.68up 3.25%
HCA Healthcare Inc $412.06up 4.79%
Tenet Healthcare Corp $205.00up 7.22%
Community Health Systems Inc $3.76up 6.21%
iShares Russell 2000 ETF $302.02up 0.90%
SPDR S&P 500 ETF Trust $750.83up 0.68%

Hospital stocks moved Thursday, but SEM is locked into a cash exit. Select Medical left its 2026 guidance unchanged in April: revenue of $5.6 billion to $5.8 billion, adjusted EBITDA of $520 million to $540 million, fully diluted EPS of $1.22 to $1.32. After the cash deal, public shareholders don’t own that outlook.

Michał Rogucki

Michał Rogucki is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic developments. A graduate of Humboldt University of Berlin, he previously worked in investment research and market analysis before transitioning to financial journalism. He covers the trends and events that matter most to investors worldwide.

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

AerCap

NYSE: AER 95 / 100
#2 BUY

Uber

NYSE: UBER 93 / 100
#3 BUY ON WEAKNESS

Taiwan Semiconductor

NYSE: TSM 91 / 100
#4 TACTICAL BUY

dLocal

NASDAQ: DLO 89 / 100
#5 BUY THE RESET

Tapestry

NYSE: TPR 86 / 100
View full portfolio
Editorial model selection. Not personalised advice.

August 14, 2026 — 08:22 ET: Stock futures mixed as oil pressure offsets fresh premarket winners

S&P 500 proxy
SPY 777.88
▲ +0.67%
Premarket indication
Nasdaq-100 proxy
QQQ 732.07
▲ +1.14%
Tech remains firmer
Dow proxy
DIA 537.91
▲ +0.14%
More subdued move
Bitcoin
$62,753
▼ −1.17%
Risk appetite mixed

U.S. equity futures remained narrowly mixed in the latest premarket trading, with technology-linked contracts outperforming while higher crude prices continued to limit broader risk appetite. The setup leaves Wall Street balancing momentum from Thursday’s record S&P 500 close against renewed concern that an oil-driven inflation impulse could complicate the Federal Reserve outlook.

Reddit surges ahead of S&P 500 inclusion

Reddit (NYSE:RDDT) remained one of the standout premarket movers, rising roughly 12% after its selection for inclusion in the S&P 500. The move reflects expected index-related buying as funds tracking the benchmark prepare for the change.

Applied Materials slides despite upbeat forecast

Applied Materials (NASDAQ:AMAT) traded sharply lower in premarket activity even after forecasting fiscal fourth-quarter revenue of about $10.25 billion, above Wall Street expectations. Investors focused instead on the pace of future growth and a margin outlook that remained broadly flat after the stock’s powerful year-to-date rally.

RDDTS&P 500 inclusion
▲ ~12%
AMATPost-earnings reaction
▼ ~5%
NVDAPremarket indication
▲ +0.54%
Premarket moves can change rapidly before the opening bell.

Oil remains the principal macro counterweight. Renewed U.S.-Iran tensions and the possibility of a prolonged naval blockade have pushed crude higher, keeping inflation sensitivity elevated just as investors prepare for the next U.S. consumer-data releases.

Strategy to sell bitcoin gives room as MSTR buyback lags new shares
Previous Story

Strategy stock gains still trail $19 billion bitcoin pile as buyback calculus moves

Regencell Bioscience (NASDAQ:RGC) slumps 63% under May offer after rebound fades
Next Story

Regencell Bioscience (NASDAQ:RGC) slumps 63% under May offer after rebound fades